Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03900832
Other study ID # STUDY00005798
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date May 15, 2019
Est. completion date July 2025

Study information

Verified date April 2024
Source Milton S. Hershey Medical Center
Contact Jian Cui, PhD
Phone 7175311799
Email jcui@pennstatehealth.psu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study objectives of this projects are to examine the hypothesis that the sympathetic and blood pressure responses to exercise will be attenuated during and after heat exposure in patients with peripheral artery disease, via altering the sensitivity of the muscle afferent receptors.


Description:

Peripheral arterial disease (PAD) affects 8-12 million Americans and its cardinal symptom is leg pain during exercise, termed "intermittent claudication". The diagnosis of PAD involves measuring the ankle-brachial index (ABI, i.e. the systolic pressure in the ankle divided by the systolic pressure in the arm); values below 0.9 are indicative of large vessel obstruction. Intermittent claudication is the most common symptom of this disease and it regularly occurs during exercise/physical activity but is relieved promptly by rest. Previous studies suggest that as the exercise pressor reflex is activated in patients with PAD, BP and heart rate (HR) are exaggerated. The BP rises during walking in the PAD patients were significantly greater than that seen in healthy control subjects. A recent human study from our group further indicates that an early BP response occurred during plantar flexion exercise before claudication was noted by the subjects, which may suggest that the accentuated BP response was due to an augmented muscle mechanoreflex in PAD. Moreover, another recent study from our group also showed that PAD patients have augmented renal vasoconstriction during plantar flexion exercise. It has been shown that exercise has benefits for patients with PAD. However, exercise becomes limited due to the pain and fatigue associated with the disease. Moreover, the augmented pressor response to exercise in PAD may increase the risk for the end organ damage (e.g. brain and/or heart). Thus, finding alternate/complimentary interventions that modulate the cardiovascular system and autonomic nervous system, and can be tolerated by the patients, would be beneficial. One possible intervention is heat exposure, since acute bouts of exercise and acute heat exposure have similar acute effects on both the autonomic and cardiovascular systems. For example, both exercise and heat exposure increase body temperature, increase HR, increase cardiac output (CO), increase left ventricular ejection fraction (EF), and enhance myocardial function. In the peripheral circulation, both exercise and heat exposure increase limb blood flow , muscle blood flow, and skin blood flow. Moreover, recent studies suggest that whole body exposure improves the endothelium function in PAD patients (e.g. activates endothelial progenitor cells CD34+). However, the effect of heat treatment on the ability of walking of PAD patients has not been examined. Moreover, it is unknown if heating can normalize/decrease the accentuated the pressor responses to exercise in PAD patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 32
Est. completion date July 2025
Est. primary completion date July 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 85 Years
Eligibility Inclusion Criteria: All subjects - Capable of giving informed consent - Any race or ethnicity - Men and women age 21- 85 years (inclusive) - Fluent in written and spoken English Patients with peripheral arterial disease (PAD) - Diagnosed with PAD (i.e., ankle-brachial index below 0.9) - Fontaine stage II or less - no pain while resting - Satisfactory history and physical exam Healthy subjects - Satisfactory history and physical examination - Free of acute medical conditions Exclusion Criteria: For patients with PAD and Healthy subjects - Age < 21 years - Pregnant or nursing women - Decisional impairment - Prisoners For patients with PAD - History of CAD with symptoms of unstable angina or myocardial infarction (<6 months) - History of epilepsy or seizure disorders For healthy subjects • Any other chronic diseases (heart, lung, neuromuscular disease or diabetes)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Without Heating
Subject will complete walking protocol without any heating procedure
Warm Bath
Subjects will sit in a warm bathtub with water up to their shoulders, while one arm will be out of water for BP and HR measurement. The water temperature and internal temperature (Tcore), BP and HR will be measured throughout the bath. The water temperature will be controlled between 38-41°C. Subjects will remain in the tub for = 30 minutes. If the HR increases more than 15 -20 bpm, or a significant BP drop occurs (e.g. BP >20 mmHg), the subject will be removed from the bath even if the time is <30 min.
Neutral Bath
Subjects will sit in a warm bathtub with water up to their shoulders, while one arm will be out of water for BP and HR measurement. The water temperature and internal temperature (Tcore), BP and HR will be measured throughout the bath. The water temperature will be controlled between 35 - 37°C. Subjects will remain in the tub for = 30 minutes.
Heating Suit
The mean skin temperature Tsk will be controlled with a water-perfused suit worn by subjects. Whole-body heating will be accomplished by perfusing warm water (~ 45 - 50 °C) through the suit to elevate the Tsk to = 38 °C (100 oF). Warm water is through plastic tubes, and subjects' skin will not directly touch warm water. The heating will be continued until the ?Tcore reaches ~ 0. 6 - 1.0 °C. This may take approximately 60 - 90 min.
Lower limb warm water immersion
Subjects will sit on a chair and put their lower legs and feet in a bucket with warm water. The water level will be just below the knees (depth of approximately 40 cm). The water temperature will be monitored and controlled at ~38 - 42 °C throughout the 30 minutes. BP, HR, Tcore, the skin temperature and skin blood flow (e.g. on a thigh and/or forearm) will be measured before, during and after the lower limbs warm water immersion.
Gardner walking protocol
The Gardner protocol begins at 2 mph and 0% grade for 2 minutes. The grade increases by 2% every 2 minutes (the speed remains 2 mph) until the subject says they want to stop or 22 minutes maximum. BP and HR will also be measured throughout the protocol.

Locations

Country Name City State
United States Penn State Milton S. Hershey Medical Center Hershey Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Milton S. Hershey Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (4)

Cui J, Blaha C, Moradkhan R, Gray KS, Sinoway LI. Muscle sympathetic nerve activity responses to dynamic passive muscle stretch in humans. J Physiol. 2006 Oct 15;576(Pt 2):625-34. doi: 10.1113/jphysiol.2006.116640. Epub 2006 Jul 27. — View Citation

Cui J, Blaha C, Sinoway LI. Whole body heat stress attenuates the pressure response to muscle metaboreceptor stimulation in humans. J Appl Physiol (1985). 2016 Nov 1;121(5):1178-1186. doi: 10.1152/japplphysiol.00212.2016. Epub 2016 Oct 7. — View Citation

Cui J, Boehmer J, Blaha C, Sinoway LI. Muscle sympathetic nerve activity response to heat stress is attenuated in chronic heart failure patients. Am J Physiol Regul Integr Comp Physiol. 2017 Jun 1;312(6):R873-R882. doi: 10.1152/ajpregu.00355.2016. Epub 2017 Mar 22. — View Citation

Cui J, Muller MD, Blaha C, Kunselman AR, Sinoway LI. Seasonal variation in muscle sympathetic nerve activity. Physiol Rep. 2015 Aug;3(8):e12492. doi: 10.14814/phy2.12492. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Walking time in minutes Walking time on treadmill using Gardner protocol Recording walking time to fatigue (up to 22 minutes maximum) during of every 3-4 hour study visit.
Primary Blood pressure in mmHg Cuffs placed on a finger and arm will monitor blood pressure. Recorded continuously during the 3-4 hour study visit
Primary Heart Rate in beats per minute Electrocardiogram (ECG) patches attached to a Cardiocap will monitor heart rat Recorded continuously during the 3-4 hour study visit
Secondary Internal Temperature in degrees C The internal temperature (Tcore) will be measured from the stomach/intestines via a telemetry pill swallowed by subjects. Recorded continuously during the 3-4 hour study visit
Secondary Near infrared spectroscopy (NIRS) in arbitrary units This system is designed specifically for non-invasive measurements of muscle tissue. The system measures the tissue saturation of the investigated muscle, called the 'tissue saturation index' (TSI). Recorded continuously during the 3-4 hour study visit
See also
  Status Clinical Trial Phase
Completed NCT03157531 - Safety and Effectiveness of B-Laser™ in Subjects Affected With Infrainguinal PAD N/A
Recruiting NCT03668353 - Recombinant SeV-hFGF2/dF Injection for PAOD Phase 1
Not yet recruiting NCT04108806 - Study of Peripheral Arterial Calcification N/A
Completed NCT02561299 - Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study N/A
Completed NCT01355406 - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System N/A
Recruiting NCT06239493 - IVUS-Guided Treatment for Percutaneous Vascular Interventions
Active, not recruiting NCT00390767 - Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) Phase 1/Phase 2
Completed NCT02907203 - Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
Recruiting NCT03686228 - Treatment of No-option CLI by G-CSF-mobilized PB-MNC N/A
Recruiting NCT03683628 - Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC N/A
Active, not recruiting NCT04204564 - VISION and VQI Paclitaxel Safety Analysis
Terminated NCT01341340 - The ABSORB BTK (Below The Knee) Clinical Investigation N/A
Completed NCT03135535 - Micro-mobile Foot Compression and Diabetic Foot Phase 2
Completed NCT03452293 - SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
Recruiting NCT05361967 - Tack Optimized Balloon Angioplasty Post-Market Study
Active, not recruiting NCT02500303 - Influence of Diabetes on Lower Limb Amputation N/A
Completed NCT03358355 - Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial Phase 1/Phase 2
Withdrawn NCT03516383 - Pulse Wave Velocity Imaging in the Assessment of PAD
Completed NCT03590769 - Arterial Imaging of Inflammation and Resolution After Endovascular Surgery Phase 1
Completed NCT01938391 - Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal N/A